This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Memantine
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
<StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='96/963765/Cv/1'> | <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='96/963765/Cv/1'> | ||
| - | Memantine is a medication used to slow the progression of moderate-to-severe Alzheimer's disease. | + | Memantine is a medication used to slow the progression of moderate-to-severe Alzheimer's disease. It is believed to work by acting on NMDA receptors, working as pore blockers of these ion channels. See also [[https://en.wikipedia.org/wiki/Memantine]]. |
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 09:08, 30 April 2023
| |||||||||||
